Brigham Young University, Provo, Utah.
Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
J Surg Res. 2024 Oct;302:463-468. doi: 10.1016/j.jss.2024.06.046. Epub 2024 Aug 20.
Prophylactic antibiotics (pABX) are commonly used prior to thyroid operations despite clean case classification. The objective of this study was to assess the association of antibiotic prophylaxis with the incidence of surgical site infection (SSI) among patients undergoing thyroidectomy.
We performed a cohort study of all adults undergoing thyroid operations at a tertiary referral center from 2010 to 2019. The primary outcome was 30-d SSI, based on diagnosis codes and/or antibiotic use and further classified based on whether wound aspiration or operative washout were required. The association between pABX and SSI was determined using propensity score matching based on patient demographics and comorbidities likely to influence SSI risk.
We identified 2411 patients who underwent thyroid operations, of whom 1358 (56.3%) received pABX. Patients who received pABX had a higher mean Charlson-Deyo Comorbidity Index score than patients who did not (3.6 versus 2.9). The unadjusted incidence of SSI was higher in patients who received pABX than those who did not (6.1% versus 3.4%, P < 0.001). Few patients with SSI required aspiration or operative washout (0.29% who received pABX versus 0.19% who did not). After propensity score matching, pABX use showed no association with overall 30-d SSI (odds ratio 1.38, 95% confidence interval 0.84-2.26) or SSI requiring procedural intervention (odds ratio 3.01, 95% confidence interval 0.24-158).
In a large cohort of patients with a high prevalence of comorbidity, use of pABX was not associated with a decreased incidence of SSI following thyroid surgery. Efforts should be made to deimplement low-value pABX use in thyroid surgery.
尽管甲状腺手术的病例分类为清洁手术,但预防性抗生素(pABX)在甲状腺手术中仍被广泛应用。本研究的目的是评估抗生素预防措施与甲状腺切除术患者手术部位感染(SSI)发生率之间的关联。
我们对 2010 年至 2019 年期间在一家三级转诊中心接受甲状腺手术的所有成年人进行了队列研究。主要结局为 30 天 SSI,基于诊断代码和/或抗生素使用,并根据是否需要伤口抽吸或手术冲洗进一步分类。使用基于患者人口统计学和可能影响 SSI 风险的合并症的倾向评分匹配来确定 pABX 与 SSI 之间的关联。
我们确定了 2411 名接受甲状腺手术的患者,其中 1358 名(56.3%)接受了 pABX。接受 pABX 的患者的平均 Charlson-Deyo 合并症指数评分高于未接受 pABX 的患者(3.6 与 2.9)。接受 pABX 的患者 SSI 的发生率高于未接受 pABX 的患者(6.1%比 3.4%,P<0.001)。接受 pABX 的患者中很少有 SSI 需要抽吸或手术冲洗(0.29%比 0.19%)。经过倾向评分匹配后,pABX 的使用与总体 30 天 SSI 无关(优势比 1.38,95%置信区间 0.84-2.26)或需要手术干预的 SSI(优势比 3.01,95%置信区间 0.24-158)。
在患有高合并症患病率的大型患者队列中,甲状腺手术后使用 pABX 与 SSI 发生率降低无关。应努力减少甲状腺手术中低价值的 pABX 使用。